GSA 2024 Abstract
NIA SBIR-FUNDED JUVENA THERAPEUTICS TRANSLATION OF POWERFUL PROTEINS INTO TRANSFORMATIVE THERAPEUTICS
Abstract
Juvena Therapeutics, which received NIA SBIR funding in 2021, was founded to restore tissue health by repairing protein signaling and intercellular communication. Juvena maps the therapeutic potential of natural secreted proteins and engineers them into biologics that restore tissue homeostasis.